文献速递关节外科

感染全髋关节置换假体取出:重复清创、间隔器长期保留与死亡的危险因素

Removal of an Infected Total Hip Arthroplasty: Risk Factors for Repeat Debridement, Long-term Spacer Retention, and Mortality.
PubMed 文献 · J Arthroplasty · 2017-03-30

基于美国国家数据库的Medicare患者分析纳入7146例因感染行髋关节假体取出并放置抗生素间隔器的患者,术后1年内6.5%院内死亡、10.8%重复清创、5.7%行切除成形术、16.8%保留间隔器、60.2%再植入(平均124.4±39.3天),并识别出多个独立的患者相关危险因素。

要点

  • 术后1年仅60.2%患者完成再植入,16.8%保留间隔器,10.8%需重复清创。
  • 术后1年内院内死亡占6.5%,切除成形术占5.7%。
  • 再植入者平均时间为124.4±39.3天。

核心结论

  • 术后1年仅60%患者接受再植入,约六分之一保留间隔器,约10%需重复清创,至少6%的患者死亡。
  • 存在多个独立的患者相关危险因素与重复清创、未再植入或1年内死亡相关。

研究设计与样本

  • 查询国家数据库纳入因感染行髋关节假体取出并放置抗生素间隔器的Medicare患者。
  • 纳入术后1年内出现研究终点者:院内死亡、1年内未再植入的重复清创、切除成形术、髋关节置换再植入。
  • 采用多变量逻辑回归分析评估上述终点的独立患者相关危险因素。
  • 共7146例患者符合全部纳入和排除标准。

主要发现

  • 术后1年内464例(6.5%)在医院内死亡。
  • 775例(10.8%)接受重复清创手术。
  • 404例(5.7%)行切除成形术。
  • 1202例(16.8%)保留间隔器,其余4301例(60.2%)再植入,平均124.4±39.3天。
  • 识别出多个独立的患者相关危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty remains the preferred approach to treatment of chronic periprosthetic joint infection (PJI) following total hip arthroplasty (THA). The objective of the present study is to investigate the fate of antibiotic spacers placed for periprosthetic joint infection after THA and evaluate risk factors for outcomes other than reimplantation. METHODS: A national database was queried for Medicare patients who underwent removal of an infected hip prosthesis and placement of an antibiotic spacer. Patients with a study end point within 1 year postoperatively were included: (1) in-hospital mortality, (2) repeat debridement without reimplantation within 1 year, (3) resection arthroplasty, and (4) reimplantation of a hip arthroplasty. Independent patient-related risk factors for these end points were evaluated with a multivariate logistic regression analysis. RESULTS: A total of 7146 patients met all inclusion and exclusion criteria. Within 1 year postoperatively, 464 patients (6.5%) died in a hospital setting, 775 patients (10.8%) had a repeat debridement procedure, 404 patients (5.7%) had a resection arthroplasty, 1202 patients (16.8%) retained their spacers, and the remaining 4301 patients (60.2%) were reimplanted at an average of 124.4 ± 39.3 days. Numerous independent patient-related risk factors for these were identified. CONCLUSION: At 1 year only 60% of patients undergo reimplantation. One-sixth of patients retain their spacer and approximately 10% require repeat debridement. Death occurred in at least 6% of the population. Several independent patient-related risk factors exist for repeat debridement, no reimplantation or death within 1 year following index THA removal.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Cancienne JM, Werner BC, Bolarinwa SA, et al. Removal of an Infected Total Hip Arthroplasty: Risk Factors for Repeat Debridement, Long-term Spacer Retention, and Mortality. J Arthroplasty. 2017. PMID: 28456558. doi:10.1016/j.arth.2017.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。